You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
濟民製藥(603222.SH):聚民生物獲一項醫療器械註冊證
格隆匯 04-06 18:27

格隆匯4月6日丨濟民製藥(603222.SH)公佈,公司全資子公司聚民生物有限公司於近日收到國家藥品監督管理局頒發的“一次性使用無菌自毀式注射器”《醫療器械註冊證》。

截至目前,公司為國內唯一一家獲得美國RTI公司授權可以在中國境內製造和銷售該產品的公司。

公司安全注射器產品生產成本高於普通注射器(約2倍左右),導致銷售價格相應提高。目前公司剛取得相關注冊證書,後續能否納入醫保範圍及納入醫保的時間存在不確定性。對公司業績影響存在不確定性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account